Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
93.36 CHF | +0.31% | +3.92% | +9.93% |
May. 13 | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
May. 10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.93% | 209B | |
+29.98% | 682B | |
+31.73% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.77% | 240B | |
-8.43% | 203B | |
+7.09% | 165B | |
-1.22% | 161B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Chinook Therapeutics' $3.5 Billion Buyout by Novartis Appreciates Value of Emerging Renal Pipeline, Oppenheimer Says